Pharmacy Technician Certification Exams — Pharmacy Technician Certification Exam Study Guide
1. Therapeutic duplication exists between:
Answer: B
Therapeutic duplication exists between aripiprazole and olanzapine.
Therapeutic duplication occurs when two medications within the same class are prescribed for a patient, which can increase the risk of adverse effects without providing additional therapeutic benefit. In this case, both aripiprazole and olanzapine are atypical antipsychotics used to treat similar psychiatric conditions, thereby qualifying as a therapeutic duplication.
A) aripiprazole and omeprazole.
This option is incorrect because aripiprazole is an atypical antipsychotic, whereas omeprazole is a proton pump inhibitor used to treat gastric acid-related disorders. These drugs belong to different therapeutic classes and do not overlap in their uses or mechanisms of action.
B) aripiprazole and olanzapine.
This option is correct as both aripiprazole and olanzapine are atypical antipsychotics that serve similar purposes in managing psychiatric disorders such as schizophrenia and bipolar disorder. Prescribing both simultaneously can lead to therapeutic duplication, which may heighten the risk of side effects without providing additional benefits.
C) amiodarone and metformin.
This option is incorrect because amiodarone is an antiarrhythmic medication used to treat heart rhythm disorders, while metformin is an oral hypoglycemic agent used to manage type 2 diabetes. These medications do not have overlapping indications and are not considered therapeutically duplicative.
D) amiodarone and buspirone.
This option is also incorrect as amiodarone and buspirone serve different therapeutic purposes. Amiodarone is utilized for cardiac arrhythmias, whereas buspirone is an anxiolytic for treating anxiety disorders. There is no therapeutic duplication between these two medications.
Conclusion
The correct answer, aripiprazole and olanzapine, represents a clear case of therapeutic duplication due to both being atypical antipsychotics with overlapping uses. In contrast, the other options involve medications from different classes or with different therapeutic indications, thereby ruling them out as instances of duplication. It is essential to avoid therapeutic duplication to minimize the risk of adverse effects and promote safe medication practices.
2. ISMP high-alert list in acute care includes antithrombotic agents such as:
Answer: A
Heparin is included in the ISMP high-alert list in acute care.
Antithrombotic agents, such as heparin, are recognized as high-alert medications by the ISMP due to their significant potential for causing harm when used inappropriately. These medications require special safeguards to reduce the risk of errors associated with their use.
A) heparin.
Heparin is an anticoagulant that is critical in preventing and treating thromboembolic disorders, making it a key component of the ISMP high-alert list in acute care settings. Its narrow therapeutic range and the consequences of dosing errors underscore the importance of heightened awareness and safety measures when it is administered.
B) amitriptyline.
Amitriptyline is a tricyclic antidepressant primarily used for depression and certain types of pain management. It is not classified as an antithrombotic agent and does not belong on the ISMP high-alert list for acute care, as its risks are not aligned with those associated with anticoagulants.
C) itraconazole.
Itraconazole is an antifungal medication used to treat various fungal infections. Like amitriptyline, it does not fit the definition of an antithrombotic agent and is not designated as a high-alert medication in the context of acute care.
D) pioglitazone.
Pioglitazone is an antidiabetic medication used to improve glycemic control in patients with type 2 diabetes. It does not have anticoagulant properties and is therefore not included in the ISMP high-alert list for antithrombotic agents in acute care settings.
Conclusion
Heparin is the only option listed that qualifies as an antithrombotic agent and is recognized as a high-alert medication due to the risks associated with its use. The other options, amitriptyline, itraconazole, and pioglitazone, do not share these characteristics and are not included in the ISMP high-alert list, emphasizing the unique safety concerns surrounding anticoagulants like heparin.
3. The Medication Errors Reporting Program (MERP) is run by the:
Answer: C
The Medication Errors Reporting Program (MERP) is run by the Institute for Safe Medication Practices (ISMP).
The Medication Errors Reporting Program (MERP) is managed by the Institute for Safe Medication Practices (ISMP), which is dedicated to improving medication safety and preventing errors.
A) Drug Enforcement Administration (DEA)
The Drug Enforcement Administration (DEA) primarily focuses on enforcing the controlled substances laws and regulations, ensuring that drugs are properly managed and preventing drug abuse. Therefore, it is not involved in managing medication error reporting.
B) Food and Drug Administration (FDA)
The Food and Drug Administration (FDA) plays a significant role in regulating medications and ensuring their safety and efficacy. However, it does not specifically run the Medication Errors Reporting Program (MERP), which is under the purview of the ISMP.
C) Institute for Safe Medication Practices (ISMP)
The Institute for Safe Medication Practices (ISMP) is the correct answer, as it operates the Medication Errors Reporting Program (MERP). This organization focuses on identifying and analyzing medication errors to improve patient safety.
D) National Association of Boards of Pharmacy (NABP)
The National Association of Boards of Pharmacy (NABP) supports state boards of pharmacy in regulating pharmacy practice. While it contributes to medication safety, it does not manage the Medication Errors Reporting Program (MERP).
Conclusion
The Institute for Safe Medication Practices (ISMP) is definitively the correct answer, as it is specifically tasked with overseeing the Medication Errors Reporting Program (MERP). All other options, while related to medication management and safety, do not have the same focus or responsibility for handling medication error reports.
Answer: C
Latuda is an atypical antipsychotic.
Latuda is classified as an atypical antipsychotic, which is used primarily to treat conditions such as schizophrenia and bipolar disorder. This medication works by affecting various neurotransmitters in the brain, particularly serotonin and dopamine.
A) Tricyclic antidepressant
Tricyclic antidepressants are a class of medications primarily used to treat depression and certain anxiety disorders. They work by inhibiting the reuptake of neurotransmitters like norepinephrine and serotonin. However, Latuda does not belong to this category, making this option incorrect.
B) Local anesthetic
Local anesthetics are substances used to block sensation in a specific area of the body during medical procedures. They act by inhibiting nerve conduction. Latuda does not serve this purpose and does not function as a local anesthetic, thus this option is also incorrect.
C) Atypical antipsychotic
Latuda is indeed an atypical antipsychotic, which is used to manage symptoms of schizophrenia and bipolar disorder. This classification is accurate as it describes how Latuda interacts with neurotransmitters and its therapeutic uses.
D) Opioid antagonist
Opioid antagonists are medications that block the effects of opioids, often used in the treatment of opioid overdose or addiction. Latuda does not have this function and is not classified as an opioid antagonist, making this option incorrect.
Conclusion
Latuda is definitively classified as an atypical antipsychotic, which distinguishes it from tricyclic antidepressants, local anesthetics, and opioid antagonists. The other options fail to accurately describe its pharmacological properties and therapeutic applications, reinforcing that C is the correct choice.
5. Which of the following medications warrants caution with respect to cross-sensitivity to penicillin?
Answer: B
Cephalexin warrants caution with respect to cross-sensitivity to penicillin.
Cephalexin is a cephalosporin antibiotic that can exhibit cross-sensitivity in individuals who are allergic to penicillin. This caution is due to the structural similarities between penicillins and cephalosporins.
A) Doxycycline
Doxycycline is a tetracycline antibiotic and does not share a structural similarity with penicillin, thus it does not warrant caution regarding cross-sensitivity. Patients with penicillin allergies can typically take doxycycline without concern for allergic reactions related to penicillin.
B) Cephalexin
Cephalexin is a cephalosporin antibiotic, which can lead to cross-sensitivity reactions in patients with a history of penicillin allergy. This is primarily due to the beta-lactam ring structure that is common to both drug classes, making caution necessary when prescribing cephalexin to those with penicillin allergies.
C) Clindamycin
Clindamycin belongs to the lincosamide class of antibiotics and does not have structural similarities to penicillin. Therefore, it does not require caution for cross-sensitivity in patients allergic to penicillin.
D) Metronidazole
Metronidazole is an antibiotic that is not related to penicillin in terms of structure or mechanism of action. As such, it does not warrant caution regarding cross-sensitivity for those with penicillin allergies.
Conclusion
Cephalexin is the only medication listed that requires caution for patients with penicillin allergies due to its structural similarities with penicillin. The other options, including doxycycline, clindamycin, and metronidazole, do not pose a risk of cross-sensitivity, making them safer alternatives for individuals with penicillin allergies. Therefore, cephalexin is definitively the correct answer in this context.
6. Which of the following medications is indicated for the treatment of schizophrenia?
Answer: C
Vraylar is indicated for the treatment of schizophrenia.
Vraylar is a medication specifically approved for the treatment of schizophrenia, making it the appropriate choice among the options listed.
A) Vyvanse
Vyvanse is primarily used to treat attention deficit hyperactivity disorder (ADHD) and is not indicated for the treatment of schizophrenia. Its mechanism of action and therapeutic effects do not address the symptoms associated with schizophrenia.
B) Vellaissa
Vellaissa is not a recognized medication for the treatment of schizophrenia. There is limited information on this option, and it does not appear to be relevant to any established treatment protocols for schizophrenia.
C) Vraylar
Vraylar is an atypical antipsychotic that is specifically indicated for the treatment of schizophrenia. It works by modulating neurotransmitter activity in the brain, thereby helping to alleviate both positive and negative symptoms associated with the disorder.
D) Valium
Valium is a benzodiazepine primarily used for anxiety and muscle spasms, and it is not indicated for the treatment of schizophrenia. While it may have sedative effects, it does not address the core symptoms of schizophrenia, such as hallucinations or delusions.
Conclusion
Vraylar is definitively the correct answer as it is the only medication listed that is specifically indicated for the treatment of schizophrenia. The other options either serve different therapeutic purposes or are not recognized treatments for this mental health condition, failing to address the specific needs of individuals with schizophrenia.
Answer: B
Errors in transcribing prescriptions may be caused by trailing zeros.
Trailing zeros can contribute to medication errors during the transcription of prescriptions, as they may lead to misinterpretation of dosages. This issue arises when a prescription states a dosage of, for example, "1.0 mg," which could be mistakenly read as "10 mg."
A) E-prescribing
E-prescribing is a technology designed to reduce errors in the prescription process by ensuring clarity and accuracy in medication orders. While it helps minimize some errors, it does not specifically lead to transcription errors associated with numeric formatting, making it an incorrect choice in this context.
B) Trailing zeros
Trailing zeros are problematic in prescription writing because they can create confusion regarding the intended dosage. For example, writing "1.0" instead of simply "1" can be misread, leading to a tenfold dosing error, which is a significant issue in medical practice.
C) Leading zeros
Leading zeros are used to prevent misreading of dosages, such as writing "0.5 mg" instead of ".5 mg." This practice is encouraged to avoid errors, making leading zeros a safe practice rather than a source of transcription errors.
D) Tall Man lettering
Tall Man lettering is a strategy to reduce medication errors by highlighting differences in drug names, especially for look-alike/sound-alike medications. While effective in promoting clarity, it does not relate to the transcription of numeric dosages, thus making it an incorrect answer.
Conclusion
Trailing zeros are a significant contributor to errors in transcribing prescriptions due to their potential to be misread, leading to serious medication errors. In contrast, e-prescribing and leading zeros are strategies aimed at reducing errors, while Tall Man lettering addresses drug name confusion rather than numeric transcription issues. Therefore, option B is the only choice that directly relates to the problem at hand.
Answer: C
Each dose of the beclomethasone dipropionate inhaler delivers 50 mcg of the drug.
To find the amount of drug delivered per dose, divide the total amount of the active ingredient (10 mg) by the number of doses (200). This calculation results in 0.05 mg per dose, which converts to 50 mcg.
A) 5
This option is incorrect because it significantly underestimates the amount of drug delivered per dose. A dose delivering only 5 mcg would imply a total of 1 mg in 200 doses, which contradicts the provided total of 10 mg.
B) 20
This option is also incorrect as it suggests that each dose delivers 20 mcg. If this were true, the total would amount to only 4 mg across 200 doses, which again does not align with the total active ingredient of 10 mg.
C) 50
This option is correct because it accurately reflects the calculation of the active ingredient per dose. Dividing 10 mg by 200 doses gives 0.05 mg, which is equivalent to 50 mcg, confirming that this is the correct amount delivered per dose.
D) 100
This option is incorrect as it implies that each dose delivers 100 mcg. If this were the case, the total would be 20 mg for 200 doses, which exceeds the actual amount of 10 mg present in the inhaler.
Conclusion
The correct answer is 50 mcg per dose, as determined by dividing the total amount of active ingredient by the number of doses. All other options either underestimate or overestimate the dosage, failing to adhere to the given total of 10 mg. Hence, option C is definitively the accurate choice.
Answer: B
The patient should receive 10 tablets.
To determine the number of tablets needed for a 1000 mg dose, it is essential to convert the tablet dosage from grams to milligrams. Since each tablet contains 0.1 g, this is equivalent to 100 mg per tablet. Therefore, dividing the total required dose of 1000 mg by the dose per tablet (100 mg) results in 10 tablets.
A) 1
This option is incorrect because administering only 1 tablet would provide a dose of 100 mg, which is far less than the required 1000 mg. The calculation shows that a higher number of tablets is necessary to meet the prescriber's order.
B) 10
This option is correct because each tablet contains 100 mg, and to achieve a total dose of 1000 mg, the calculation shows that 10 tablets must be administered (1000 mg ÷ 100 mg/tablet = 10 tablets).
C) 100
This option is incorrect as it suggests administering 100 tablets, which would provide a total dose of 10,000 mg (100 mg x 100 tablets). This amount exceeds the prescribed dose of 1000 mg by a significant margin.
D) 1000
This option is also incorrect because giving 1000 tablets would result in a total dose of 100,000 mg (100 mg x 1000 tablets). Such an amount is excessively higher than the prescribed dose and would not be appropriate.
Conclusion
The correct answer is 10 tablets, as this aligns with the required dose of 1000 mg, based on the strength of each tablet being 100 mg. All other options fail because they either underdose or overdose the patient significantly, demonstrating a clear misunderstanding of the dosage calculation required.
Answer: B
Sanitizing pharmacy countertops should be done using a disinfectant.
To ensure a safe and clean environment, pharmacy countertops should be sanitized with a disinfectant, as recommended by the Centers for Disease Control and Prevention (CDC). Disinfectants are specifically designed to eliminate harmful microorganisms on surfaces.
A) Antiseptic
Antiseptics are used primarily on living tissues to reduce the possibility of infection, not on surfaces like pharmacy countertops. Therefore, while antiseptics are important in healthcare settings, they are not appropriate for sanitizing countertops.
B) Disinfectant
Disinfectants are chemical agents specifically formulated to destroy bacteria, viruses, and fungi on surfaces. According to the CDC, using a disinfectant on pharmacy countertops is appropriate as it effectively sanitizes these areas to prevent the spread of pathogens.
C) Antimicrobial
Antimicrobial agents inhibit the growth of microorganisms but are not always suitable for surface sanitation. While they can be beneficial in certain contexts, they do not have the specific efficacy of disinfectants for cleaning countertops in a pharmacy setting.
D) Decontaminant
Decontaminants are used to reduce or eliminate contamination, but this term is broader and less specific than disinfectants. While decontaminants can be effective, they do not necessarily denote the same level of efficacy required for sanitizing pharmacy countertops, which is best achieved through disinfectants.
Conclusion
Disinfectants are the most effective choice for sanitizing pharmacy countertops, as they are specifically designed to eliminate pathogens on non-living surfaces. The other options, including antiseptics, antimicrobials, and decontaminants, do not fulfill the specific requirements outlined by the CDC for this purpose. Therefore, selecting a disinfectant is essential for maintaining a safe pharmacy environment.